How to Get Rid of Cold Sores Inside Your Mouth

Intraoral cold sores, caused by herpes simplex virus type 1 (HSV-1), are treated primarily with antiviral medications like acyclovir or valacyclovir, combined with supportive measures for pain relief and healing. Unlike the more familiar cold sores that appear on or around the lips, lesions inside the mouth can be trickier to manage and easier to confuse with other conditions. The treatment approach depends on whether you are dealing with a first outbreak or a recurrence, and how well your immune system is functioning.

Cold Sores Inside the Mouth vs. Canker Sores

Before reaching for treatment, it helps to know what you are actually dealing with. Cold sores inside the mouth and canker sores (aphthous ulcers) look somewhat similar but have completely different causes and treatments. Cold sores are viral, caused by HSV-1, and are contagious. Canker sores are not caused by a virus, are not contagious, and their exact cause is still debated, though nutritional deficiencies, stress, and immune dysfunction all play roles. People with recurrent canker sores tend to have lower dietary intake of vitamin B12 and folate compared to the general population.

1PubMed Central. Reduced dietary intake of vitamin B12 and folate in patients with recurrent aphthous stomatitis

Intraoral herpes lesions tend to appear on the hard palate, the gums, and other keratinized (firm, attached) tissue inside the mouth. Canker sores, by contrast, favor soft, movable tissue like the inner cheeks, the floor of the mouth, and the soft palate. Herpes sores often start as clusters of tiny blisters that merge and rupture into shallow ulcers, while canker sores usually appear as single, round ulcers with a white or yellowish center and a red border. If you see a crop of small blisters on your gums or the roof of your mouth, that pattern strongly suggests herpes rather than canker sores. Getting the diagnosis right matters because antiviral drugs work on cold sores but do nothing for canker sores, and vice versa for some canker sore treatments.

First Outbreak vs. Recurrences

A first episode of oral herpes, called primary herpetic gingivostomatitis, can be far more dramatic than any recurrence. It often involves widespread painful sores across the gums, tongue, and palate, along with fever, swollen lymph nodes, and difficulty eating or drinking. Although this primary infection is more commonly reported in children, adults can experience it too.

2Europe PMC. Acute primary herpetic gingivostomatitis

HSV-1 is typically transmitted during childhood through direct contact and then establishes lifelong latency in nerve tissue, specifically the trigeminal ganglia, which serve the face and mouth. From there, the virus can reactivate periodically, traveling back along nerve fibers to cause new sores.

3Cureus. Trigeminal Neuralgia Secondary to Herpes Simplex Virus Type 1 Infection Treated With Oral Acyclovir Recurrent intraoral outbreaks are usually milder than the first episode, involving fewer sores, less pain, and no systemic symptoms like fever. That said, they can still be quite uncomfortable, especially when sores land on the gums or palate where food constantly contacts them.

Antiviral Medications

Prescription antivirals are the backbone of cold sore treatment, whether the sores are on the lips or inside the mouth. The two most commonly used are acyclovir and valacyclovir. Valacyclovir is actually a prodrug of acyclovir, meaning your body converts it into acyclovir after you swallow it, but it is absorbed more efficiently, so you can take fewer pills per day to get the same effect.

For recurrent outbreaks, the evidence supports starting treatment as early as possible, ideally at the first tingle or sign of a sore. In large placebo-controlled trials, a short course of valacyclovir reduced the duration of a cold sore episode by roughly a day compared to placebo, and it shortened healing time and pain duration as well.

4PubMed Central. High-dose, short-duration, early valacyclovir therapy for episodic treatment of cold sores: results of two randomized, placebo-controlled, multicenter studies One day may not sound like much, but when you are dealing with painful mouth sores that make eating miserable, cutting the episode short by even 24 hours is meaningful.

In cases where acyclovir alone does not fully control recurrent intraoral herpes, switching to valacyclovir has shown better clinical results. One documented case found that a patient whose intraoral lesions kept recurring on acyclovir experienced complete resolution after switching to valacyclovir, with no new lesions appearing.

5e-GiGi. Clinical Response Difference between Acyclovir and Valacyclovir in Recurrent Intraoral Herpes: Adaptation Treatment in Pandemic Situation This does not mean acyclovir fails for everyone. It remains a standard first-line treatment, especially for primary outbreaks, and is available in both oral and topical forms. But if you find that acyclovir is not controlling your outbreaks well, asking your doctor about valacyclovir is a reasonable next step.

For intraoral sores specifically, topical antiviral creams are less practical than they are for lip sores, since saliva washes them away quickly. Oral (swallowed) antiviral tablets are the preferred route when sores are inside the mouth.

Adding a Topical Corticosteroid

One question that comes up is whether adding a corticosteroid alongside an antiviral helps. It sounds counterintuitive, since steroids suppress immune activity and you would think that is the last thing you want during a viral infection. But a systematic review pooling results from multiple trials found that combining a topical corticosteroid with antiviral therapy significantly reduced the chance of sores progressing to full ulcerative lesions compared to either placebo or antiviral treatment alone. The combined approach did not increase the rate of side effects.

6BMC Infectious Diseases. Effectiveness of topical corticosteroids in addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis

The catch is that healing time was not significantly shorter with combined therapy compared to antiviral alone. So the steroid appears to help prevent sores from fully forming if you catch things early, but once an ulcer has established itself, it does not speed up healing beyond what the antiviral already does. This approach should only be used under medical guidance, since applying steroids to a herpes lesion without an accompanying antiviral could make things worse by allowing the virus to replicate unchecked.

Supportive Care for Pain and Healing

While antivirals attack the virus itself, you still need to manage the pain and help the sores heal. Intraoral cold sores can make eating, drinking, and even talking uncomfortable. A few straightforward measures help considerably.

Rinsing with saline (salt water) several times a day keeps the sores clean and can reduce bacterial contamination that slows healing. In a documented case of severe recurrent intraoral herpes, a regimen that included saline rinses, a hyaluronic acid mouthwash, systemic acyclovir, and multivitamins led to significant pain reduction and lesion improvement within seven days.

7Jurnal Medali. Beyond A Common Infection: Comprehensive Oral Management Strategies For Severe Recurrent Intraoral Herpes Hyaluronic acid mouthwashes are available over the counter in many countries and create a temporary protective film over oral ulcers, which can make eating less painful.

Over-the-counter topical numbing agents containing benzocaine or lidocaine provide temporary pain relief when applied directly to sores. These do not speed healing, but they can make mealtimes tolerable. Avoiding acidic, spicy, or very hot foods during an outbreak is common sense that makes a real difference in day-to-day comfort. Cold foods and drinks tend to be soothing. Staying hydrated matters because dehydration is a genuine risk during severe primary outbreaks, especially in children who refuse to eat or drink because of mouth pain.

Lysine, Arginine, and Dietary Approaches

You will encounter a lot of enthusiasm online for L-lysine supplements as a cold sore remedy. The idea has a plausible biological basis: in tissue culture, arginine deficiency suppresses herpes virus replication, and lysine acts as an antagonist to arginine, effectively competing with it.

8PubMed. Relation of arginine-lysine antagonism to herpes simplex growth in tissue culture The leap from a petri dish to your mouth is a big one, though.

A review of the clinical evidence found that lysine supplementation at doses under 1 gram per day, without also restricting dietary arginine, appears to be ineffective for preventing or treating herpes outbreaks. Higher doses, above 3 grams per day, do seem to improve how patients feel during outbreaks, though the evidence for actually preventing outbreaks remains thin.

9PubMed Central. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence In practical terms, if you want to try lysine, the casual dose many people take (500 mg once a day) probably is not enough to do anything. And the higher doses that might help are not a substitute for antiviral medication during an active outbreak.

The arginine side of the equation is worth knowing about. Foods particularly high in arginine include nuts, seeds, chocolate, and some grains. Some people who get frequent outbreaks report that cutting back on these foods reduces recurrences, but controlled studies confirming this are scarce. It falls into the “probably will not hurt to try, but do not rely on it” category.

Stress and Reactivation

The link between stress and cold sore outbreaks is not just folklore. Research has demonstrated a direct mechanism: psychological stress reduces the number and function of CD8+ T cells that patrol the nerve ganglia where HSV-1 hides. In animal studies, restraint stress caused roughly a 65% reduction in T cells capable of responding to reactivating virus.

10PubMed Central. Psychological stress compromises CD8+ T cell control of latent herpes simplex virus type 1 infections When these immune sentinels are depleted or impaired, the virus can temporarily escape from latency and travel back to the skin or mucosa to cause a new outbreak.

This does not mean every stressful week will produce a cold sore. The relationship is probabilistic, not guaranteed. But if you notice a pattern of outbreaks following periods of sleep deprivation, emotional stress, or illness, the connection is immunologically real. Managing stress through sleep, exercise, and whatever else works for you is a legitimate part of reducing outbreak frequency, alongside the more obvious medical interventions.

Dental Procedures as a Trigger

If you have ever had a cold sore flare up shortly after a dental visit, you are not imagining things. Dental procedures, particularly tooth extractions performed under local anesthesia, can trigger HSV-1 reactivation. Severe and extensive herpes outbreaks have been documented soon after dental extractions.

11PubMed. Severe herpes simplex virus type-I infections after dental procedures The likely mechanism is procedure-related nerve damage, since the trigeminal nerve branches that serve the teeth are the same nerves where HSV-1 sits dormant. Disturbing those nerves appears to prod the virus into action.

Research measuring oral HSV-1 shedding before and after dental procedures found that molar extraction increased the rate of viral shedding, with the highest rates seen after extractions done under general anesthesia.

12PubMed. Herpes simplex virus reactivation and dental procedures If you are someone who reliably gets cold sores after dental work, it is worth mentioning this to your dentist. Some clinicians will prescribe a short course of prophylactic antivirals to take before and after the procedure to head off an outbreak.

Preventing Spread to Other Body Sites

During an active outbreak, HSV-1 can spread from an existing sore to other parts of your body through a process called autoinoculation. This is especially a concern with intraoral sores because you naturally touch your mouth frequently, and active lesions are shedding virus. A case report documented an infant who spread herpes from an oral infection to her chest and face by rubbing her hand on other body parts.

13PubMed Central. Herpes simplex transmission to chest and face through autoinoculation in an infant

Autoinoculation is more of a risk during primary infections, when the immune system has not yet built up antibodies against HSV-1. Once you have had the virus for a while and have established antibody responses, spreading it to new body sites becomes less likely but is not impossible, particularly if your immune system is weakened. During an active outbreak, wash your hands frequently, avoid touching the sores and then touching your eyes (herpes keratitis is a serious eye infection), and do not share utensils or drinking glasses.

When Cold Sores Become Dangerous

For most people with healthy immune systems, intraoral cold sores are painful and annoying but self-limiting. They clear up on their own within a week or two even without treatment, though antivirals speed things along and reduce discomfort. The calculus changes dramatically for immunocompromised individuals.

People undergoing chemotherapy are at particular risk. HSV infection is widespread in this group, and outbreaks can be severe because the immune suppression from treatment allows the virus to replicate aggressively. Treatment should begin as soon as possible using antivirals to prevent complications.

14PubMed Central. Oral herpes simplex virus infection in patients undergoing chemotherapy – an integrative review In healthy patients, herpes infections are usually mild and self-limiting, but in immunocompromised patients they are frequently more aggressive, persistent, and can even become life-threatening.

15PubMed. Management of oral herpes simplex virus infections: The problem of resistance. A narrative review

Another concern in immunocompromised patients is antiviral resistance. When the virus is exposed to acyclovir or valacyclovir repeatedly in a setting where the immune system cannot help finish the job, resistant strains can emerge. This is uncommon in people with normal immune function but is a recognized clinical problem in transplant recipients, cancer patients, and people with advanced HIV. Resistant cases may require second-line antivirals such as foscarnet or cidofovir, which have more side effects than acyclovir-class drugs.

Laser Treatment

Low-level laser therapy is an option that has gained traction in dental offices for managing oral herpes lesions and aphthous ulcers alike. In a controlled trial comparing diode laser treatment to acyclovir cream for herpes sores, the laser group had a mean recovery time of about 2.2 days compared to 3.4 days in the acyclovir group, and pain duration was shorter as well.

16PubMed Central. Comparing the effect of diode laser against acyclovir cream for the treatment of herpes labialis A separate trial using a 940 nm diode laser on oral ulcers found reductions in pain intensity, ulcer diameter, and healing time compared to conventional medication.

17PubMed. Treatment of recurrent minor aphthous stomatitis using diode laser (940 nm)

Laser treatment has the advantage of providing immediate pain relief during the session, and some evidence suggests that treating the site with laser between outbreaks can reduce the frequency of recurrences, though the data on that is still limited. The downsides are availability and cost. Not every dental office has the equipment, and the treatment may not be covered by insurance. It is best thought of as a useful adjunct, particularly for people who get frequent outbreaks in the same location inside the mouth, rather than a replacement for antiviral medication.

Drugs in the Pipeline

The current generation of antivirals all work by the same basic mechanism, targeting a viral enzyme called DNA polymerase. That shared mechanism means that resistance to one tends to confer resistance to the others, which is a problem for patients who need alternatives. A newer class of drugs targets a different viral protein complex called the helicase-primase complex. Pritelivir, the most advanced of these, is currently in phase 3 clinical trials, and a related compound called IM-250 is in phase 1 trials. Another helicase-primase inhibitor, amenamevir, is already approved for clinical use in Japan against HSV and varicella-zoster virus.

18Cell. Structures of the herpes simplex virus 1 replication fork and helicase-primase complexes bound to inhibitors

These drugs matter because they work through a completely different mechanism than acyclovir and its relatives, which means they can be effective against acyclovir-resistant strains. For most healthy people dealing with occasional intraoral cold sores, current antivirals work fine. But for immunocompromised patients facing resistant infections, the arrival of helicase-primase inhibitors in wider clinical use could be a significant advance. A therapeutic vaccine for HSV-1 has also been a longstanding goal, but despite decades of effort, no vaccine has reached the market. Research continues, and some candidates are in early clinical trials, though expectations should remain measured given the history of setbacks in this field.